
1644: Shock Opera
Risks and Side Effects of GLP-1 Weight Loss Medications
ABC News medical correspondent Dr. Jen Ashton discussed the safety profile of GLP-1 drugs, noting they have been FDA-approved for type 2 diabetes for nearly 20 years. While the segment downplayed risks like pancreatitis and thyroid cancer as rare, critics pointed out that a 1% risk rate is significant when applied to millions of users. The discussion highlighted the lack of long-term human studies on the effects of these drugs when used specifically for weight loss in non-diabetic populations.










